Impedimed Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Public

  • Employees
  • 104

Employees

  • Stock Symbol
  • IPD

Stock Symbol

  • Investments
  • 2

Impedimed General Information

Description

Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates the majority of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The company recognises revenue from the stand-alone sale of Legacy Devices and Consumables, the Sale of SOZO Devices, and Software Subscription Services.

Contact Information

Website
www.impedimed.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 5900 Pasteur Court
  • Suite 125
  • Carlsbad, CA 92008
  • United States
+1 (760)
Primary Industry
Monitoring Equipment
Stock Exchange
ASX
Vertical(s)
Manufacturing, HealthTech, Life Sciences
Corporate Office
  • 5900 Pasteur Court
  • Suite 125
  • Carlsbad, CA 92008
  • United States
+1 (760)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Impedimed Stock Performance

As of 13-Nov-2026, Impedimed’s current market cap is $10M with 3.67B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10M 3.67B 6.17M

Impedimed Financials Summary

As of 30-Sep-2026, Impedimed has a trailing 12-month revenue of null.

In Thousands,
USD 		TTM 30-Sep-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV 13,713 14,455 35,478 73,174
Revenue 9,899 8,233 6,588
EBITDA (11,531) (11,933) (12,432)
Net Income (16,873) (15,035) (12,969)
Total Assets 23,853 27,212 31,405
Total Debt 11,421 9,465 764
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Impedimed Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Impedimed‘s full profile, request access.

Request a free trial

Impedimed Patents

  • 459

    Total Documents Applications and Grants

  • Total Patents Families

  • 221

    Granted

  • 12

    Pending

  • Expiring in next 12 mo

Impedimed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230346239-A1 Impedance measurement device Inactive 28-Apr-2022
US-D1030531-S1 Impedance measurement device Active 28-Apr-2022
AU-2019348188-A1 Evaluating impedance measurements Active 27-Sep-2018
AU-2019348188-B2 Evaluating impedance measurements Active 27-Sep-2018
EP-3856024-A1 Evaluating impedance measurements Active 27-Sep-2018 A61B5/0537
To view Impedimed’s complete patent history, request access »

Impedimed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Impedimed Acquisitions (2)

Impedimed’s most recent deal was a Merger/Acquisition with Intersection Medical. The deal was made on 26-Oct-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Intersection Medical 26-Oct-2015 Merger/Acquisition Surgical Devices
XiTRON Technologies 01-Oct-2007 Merger/Acquisition Electronic Equipment and Instruments
To view Impedimed’s complete acquisitions history, request access »

Impedimed ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Impedimed’s complete esg history, request access »

Impedimed Exits (1)

Impedimed’s most recent exit was on 01-Oct-2007 from XiTRON Technologies. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
XiTRON Technologies 01-Oct-2007 Completed
To view Impedimed’s complete exits history, request access »

Impedimed FAQs

  • When was Impedimed founded?

    Impedimed was founded in 1999.

  • Where is Impedimed headquartered?

    Impedimed is headquartered in Carlsbad, CA.

  • What is the size of Impedimed?

    Impedimed has 104 total employees.

  • What industry is Impedimed in?

    Impedimed’s primary industry is Monitoring Equipment.

  • Is Impedimed a private or public company?

    Impedimed is a Public company.

  • What is Impedimed’s stock symbol?

    The ticker symbol for Impedimed is IPD.

  • What is the current market cap of Impedimed?

    The current market capitalization of Impedimed is $10M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process